Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts.

Cattaneo, Dario; Corbellino, Mario; Gervasoni, Cristina

Cattaneo, Dario; Corbellino, Mario; Gervasoni, Cristina.

Cattaneo D; Unit of Clinical Pharmacology, Fatebenefratelli Sacco University Hospital, Milan, Italy. dario.cattaneo@asst-fbf-sacco.it.
Corbellino M; Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy. dario.cattaneo@asst-fbf-sacco.it.
Gervasoni C; 3rd Division of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.

Eur J Clin Pharmacol ; 77(5): 791-792, 2021 05.

Article in English | MEDLINE | ID: covidwho-947026

Subject(s)

COVID-19 Drug Treatment; Ritonavir; Antiviral Agents/therapeutic use; Humans; Lopinavir; Ritonavir/pharmacology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ritonavir / COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Eur J Clin Pharmacol Year: 2021 Document Type: Article Affiliation country: S00228-020-03053-1

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google